secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2026-07-06T20:22:14+00:00
Accession:  0001193805-26-000916
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Tamar Howson resigns; CEO Erik Lundgren appointed to board
-------------------------------------------------------------------

- Tamar Howson resigned from Board and Compensation Committee effective June 29, 2026, due to retirement; no disagreement.
- On July 5, 2026, Board appointed CEO Erik Lundgren as Class II director until 2028 annual meeting.
- Lundgren will not serve on any board committee and receives no additional compensation for director role.
- Lundgren's existing employment agreement with Immunic was previously disclosed (May 27, 2026 8-K).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380526000916/0001193805-26-000916-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380526000916/e665619_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-26-000916

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer